2020-03-27
On the afternoon of March 26, 2020, Wen
Zhifen, Chairman of the Board, and Liang Zhixiong, President of the Group,
along with their team, visited Zhaoqing Dahuanong for research and guidance.
They were accompanied by Chen Rui'ai, President of the Dahuanong Business
Division, and other members of the leadership team during the visit.
Members of the Group Board's Research Team
listened to an introduction of the production and operation status of Zhaoqing Dahuanong
Chairman Wen Zhifen and his delegation toured the first, third, and under-construction P3 workshops, as well as the diagnostic reagent workshop at Zhaoqing Dahuanong. They gained a detailed understanding of the achievements made in recent years in production technology and scientific innovation, and listened to a report on the current state of the animal health industry and the development plans for the fifth five-year period. They expressed full affirmation for the achievements made by the Dahuanong Business Division and offered specific guidance on how to maintain high-quality development.
Members of the Group
Board's Research Team listened to an introduction of the scientific and
innovative situation at Dahuanong
President Liang Zhixiong pointed out that the animal health industry of Dahuanong is a high-tech industry, and it is necessary to achieve high-quality development in the future. Firstly, increase investment in scientific research to introduce new products with significant advantages. Secondly, strengthen the construction of management and technical teams to cultivate a high-end and elite team. Thirdly, intensify marketing efforts to create a brand effect. Fourthly, enhance the combination of independent development and cooperative development to promote high-quality development of Dahuanong through win-win cooperation. Fifthly, build a modern enterprise management and monitoring system.
Members of the Group Board's Research Team listened to an introduction of the inactivated vaccine workshop renovation (expansion) P3 project at Zhaoqing Dahuanong.
Chairman Wen Zhifen highly recognized the
five-year strategic layout of the Dahuanong Business Division, demanding that
the business division should dare to set higher and more long-term development
goals, strengthen cooperation with synergistic and related industries, and
maintain a top three position in the industry. Increase investment in
scientific research and build the capabilities of research teams, seize market
opportunities, accelerate the transformation and output of scientific and
technological achievements, and achieve breakthrough growth. Boldly introduce
young, influential leading talents or high-quality talents to create more
opportunities for the development of the animal health industry. Improve the
enterprise control system, promote organizational system innovation, and boldly
propose policy proposals that are conducive to the progress of the business.
Group board of directors research team
members thoroughly understand the application and promotion of African swine
fever fluorescent PCR detection kits
The management team of the Dahuanong Business Division has expressed that they will fully comprehend and implement the requirements set forth by the group, manage, develop, and grow the animal health industry, and move forward towards newer, higher, and more ambitious goals.
Written by the Administrative Department of Dahuanong Business Division.
Photo by Xie Xiaofei from Zhaoqing Dahuanong